Close Menu

NEW YORK (GenomeWeb News) — GeneNews said today that it has signed up a lab services provider to expand its colon cancer risk test in Southwestern Ontario.

Gamma-Dynacare Medical Laboratories will provide blood specimen collection services for the ColonSentry test from three of its patient service centers in London, Ontario. The company estimated that the agreement has potentially made its test available to the nearly 500,000 people in this region of Ontario who are between 50 and 79 years old.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A new study finds that three dimensional facial scans may be able to aid in diagnosing rare genetic diseases.

The Lancet and the New England Journal of Medicine have retracted two COVID-19 papers due to concerns about the data used in their analyses.

Lawmakers plan to introduce a bill that aims to prevent the theft of US-funded research, according to the Wall Street Journal.

In Science this week: analysis of ancient Caribbean islanders' genomes suggests at least three waves of migration into the region,  DNA barcoding of microbial spores, and more.

Jul
15
Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.